1. Associating structural characteristics to immunomodulating properties of carrot rhamnogalacturonan-I fractions.
- Author
-
Desai K, Dobruchowska JM, Elbers K, Cybulska J, Zdunek A, Porbahaie M, Jansen E, Van Neerven J, Albers R, Wennekes T, Mercenier A, and Schols HA
- Subjects
- Humans, Cytokines metabolism, Molecular Weight, Immunomodulating Agents pharmacology, Immunomodulating Agents chemistry, Pectins chemistry, Pectins pharmacology, Daucus carota chemistry, Leukocytes, Mononuclear drug effects
- Abstract
Carrot rhamnogalacturonan-I (cRG-I) is a polydisperse polysaccharide with molecular weights of 7-250 kDa. Using size exclusion chromatography cRG-I was fractionated and pooled in fractions (PF1-6). All fractions contained the same RG-I monosaccharides and similar glycosidic linkages although in varying relative amounts. The main differences were in rhamnose substitution, arabinan- and galactan side chain length and in levels of acetylation and methyl esterification. Atomic force microscopy showed either spheric or elongated structures for cRG-I and its derived fractions. To gain insight in the structure-function relationship of cRG-I, the immunomodulatory effect of the six fractions and their saponified derivatives was assessed in vitro. All fractions, except PF2, dose-dependently stimulated TNFα, IL-6, IL-1β, IL-8 and IL-10 production in peripheral blood mononuclear cells (PBMCs) of three healthy donors. Cytokine levels were largely influenced by the Mw and degree of esterification of the individual fractions. Notably, the highest Mw fraction (100 kDa) displayed the most potent activity, which was strongly reduced after the removal of ester residues by saponification. In contrast, the 75 kDa Mw population (PF2) proved inactive while its saponified counterpart exhibited substantial immunomodulatory activity. This confirmed the role of ester residues on the immune profile of RG-I subpopulations., Competing Interests: Declaration of competing interest The authors declare the following financial interests which may be considered as potential competing interests. NutriLeads holds intellectual property rights for the use cRG-I. Annick Mercenier and Ruud Albers were employed at NutriLeads and remain shareholders affiliated to NutriLeads for scientific matters., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF